Patients News | pharmaphorum

News

EMA review finds AZ COVID-19 vaccine “safe and effective”

An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall risk of blood clots with this vaccine.

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

States halting AZ jab a ‘disaster’ for EU’s COVID vaccinatio...

The decision by around a dozen EU countries to suspend dosing with AstraZeneca’s COVID-19 vaccine is facing criticism, amid fears that it could undermine the response to the pandemic in Eur

News

EU regulators probe safety of AstraZeneca vaccine batch afte...

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use

News

NIH abandons convalescent plasma trial in mild COVID

Another trial of convalescent plasma in people with COVID-19 has missed the mark, this time in mild to moderate disease, further dashing hopes that the therapy could have an impact on the i

News

Roche introduces 15-minute nasal COVID test in UK

Roche Diagnostics has launched a 15-minute nasal antigen test for COVID-19 in the UK, and says it has millions of the kits avai

News

AZ COVID jab efficacy debate is hindering EU’s vaccine drive

The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to undermine the EU’s vaccination targets.

EMA review finds AZ COVID-19 vaccine “safe and effective”

States halting AZ jab a ‘disaster’ for EU’s COVID vaccinatio...

EU regulators probe safety of AstraZeneca vaccine batch afte...

NIH abandons convalescent plasma trial in mild COVID

Roche introduces 15-minute nasal COVID test in UK

AZ COVID jab efficacy debate is hindering EU’s vaccine drive

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks